China Finance Inc
Change company Symbol lookup
Select an option...
CHFI China Finance Inc
SU Suncor Energy Inc
CUBI Customers Bancorp Inc
SMIT Schmitt Industries Inc
BA Boeing Co
AMSWA American Software Inc
V Visa Inc
SVFB SVF Investment Corp 2
DMO Western Asset Mortgage Opportunity Fund Inc
SHAK Shake Shack Inc
Go

Financials : Capital Markets |
Company profile

China Finance, Inc., through its wholly owned subsidiary, Shenzhen Hua Yin Guaranty and Investment Limited Liability Corporation (SHY), is engaged in providing surety guarantees for privately owned small and medium enterprises (SMEs) (or operating companies) in the People’s Republic of China entering into transactions, whereby the SME will be acquired by a publicly traded United States reporting company in a reverse merger or other merger and acquisition transaction; providing loan guarantees to assist SMEs and individuals in China in obtaining loans from Chinese banks for business operations and/or personal use, and making direct loans to SMEs for business operations. In addition, the Company is seeking direct investments (including, without limitation, controlling investments) in SMEs that would be made through the Company’s wholly owned subsidiary, Value Global International Limited.

Closing Price
$0.00
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.00
Day's Low
0.00
Volume
10,000

Thinking about buying stock in Panbela Therapeutics, Vyne Therapeutics, AT&T, Jasper Therapeutics, or Marathon Digital?

10:54 am ET January 10, 2023 (PR Newswire) Print

InvestorsObserverissues critical PriceWatch Alerts for PBLA, VYNE, T, JSPR, and MARA.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- PBLA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=PBLA&prnumber=011020235

-- VYNE: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=VYNE&prnumber=011020235

-- T: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=T&prnumber=011020235

-- JSPR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=JSPR&prnumber=011020235

-- MARA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=MARA&prnumber=011020235

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG82710&sd=2023-01-10

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-panbela-therapeutics-vyne-therapeutics-att-jasper-therapeutics-or-marathon-digital-301718018.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG82710&Transmission_Id=202301101054PR_NEWS_USPR_____CG82710&DateId=20230110

comtex tracking

COMTEX_422426726/1005/2023-01-10T10:54:10

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.